Eating Frequency for Weight Loss
(HEP Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to address the gap in knowledge regarding the relationship between eating frequency and weight loss.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking weight loss medication, you would not be eligible to participate.
What data supports the effectiveness of the treatment Eating Frequency for weight loss?
Research suggests that increasing eating frequency might not significantly help with weight loss, as studies show no major changes in body weight when people change how often they eat. Some studies even suggest that eating more frequently could lead to a higher energy intake, which might not be helpful for losing weight.12345
Is eating frequency generally safe for humans?
How does the treatment of eating frequency differ from other weight loss treatments?
Eating frequency as a treatment for weight loss is unique because it focuses on the timing and number of meals rather than the specific content of the diet. This approach aims to increase metabolism, reduce hunger, and improve glucose and insulin control by adjusting how often you eat, which is different from traditional calorie-restriction diets.128910
Research Team
Hollie A Raynor, PhD, RD
Principal Investigator
University of Tennessee
Eligibility Criteria
This trial is for healthy adults aged 18 to 65 who are overweight or obese, with a BMI between 27 and 45. It's not suitable for those outside this age range or BMI criteria.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow a lifestyle intervention with either three meals per day or increased eating frequency for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Eating Frequency
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor